INTRODUCTION
Loose connective tissue structures surround all peripheral blood and lymph vessels, nerves and muscles, as well as underlying epithelial sheets forming what is commonly referred to as the interstitium. The interstitium harbours the extracellular fluid, whose volume amounts to some 15% of the total body weight. Interstitial fluid volume is determined by the influx of fluid across the capillary wall and drainage
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c 2018 The Authors Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society via the lymphatics. Capillary filtration is determined by the colloidal osmotic pressures across the capillary wall and the capillary pressure that is determined from the myogenic activity of the smooth muscle in the microvasculature and the permeability of the microvascular barrier (Curry & Adamson, 2013; Michel & Curry, 1999) • What is the main finding and its importance? interstitial compliance, but as we have shown, it is also actively controlled by connective tissue cells. In skin P IF is normally slightly below ambient pressure, i.e. around −1 mmHg compared at a capillary hydostatic pressure of around 10 mmHg and a net capillary pressure, i.e. the net pressure that creates filtration across the capillaries, of 0.5-1 mmHg (Reed, Liden, & Rubin, 2010) . P IF normally acts to maintain a constant interstitial volume while in particular conditions like inflammation a lowered P IF transiently becomes the main driving force for the rapid initial fluid movement out of the microvasculature during early innate immunity responses (Reed et al., 2010) . A lowering of P IF by even a few mmHg will represent an important part of the driving force for capillary filtration together with increased capillary hydrostatic pressure and increased capillary permeability since the lowering of P IF must be compared with a net capillary filtration pressure of a 0.5-1 mmHg (Reed et al., 2010) . Once oedema has formed, P IF will reach positive values and further maintenance of filtration and oedema relies on increased capillary hydrostatic pressure and increased capillary permeability.
Under steady-state conditions connective tissue cells balance the slightly negative P IF by exerting tensional forces that maintain the proteoglycan/hyaluronan ground substance of the extracellular matrix (ECM) in an underhydrated state (Reed et al., 2010) . The necessary force is generated by the cytoskeletal machinery that connects to ECM fibres via integrins (Berg, Rubin, & Reed, 2001; Reed, Rubin, Wiig, & Rodt, 1992) . At homeostasis 1 -integrins are operative in rat and mouse dermis whereas during inflammatory reactions, in which P IF is lowered, e.g. during anaphylaxis, there is a shift in integrin usage such that the V 3 -integrin, and not 1 -integrins, connects the cellular contractile apparatus to ECM fibres (Liden, Berg, Nedrebø, Reed, & Rubin, 2006; Svendsen, Liden, Nedrebø, Rubin, & Reed, 2008) .
Available data suggest that the collagen-binding integrins 2 1 (Rodt, Ahlen, Berg, Rubin, & Reed, 1996) and 11 1 (Svendsen et al., 2009) are operative to maintain a homeostatic P IF in rat and mice dermis, respectively. In 11 1 -deficient mice blockage of 1 -integrins does not lower P IF whereas such blockage lowers P IF in wild-type mice (Reed et al., 1992; Svendsen et al., 2009) . Local administration of plateletderived growth factor (PDGF)-BB normalizes P IF in mouse and rat dermis in which P IF has been lowered by mast cell degranulation (Liden et al., 2006; Rodt et al., 1996) . This effect of PDGF-BB requires functional integrin V 3 (Liden et al., 2006) . Furthermore, dermal P IF is not significantly lowered in 11 1 -deficient mice, but readily lowered in wild-type mice during compound 48/80 (C48/80)-induced anaphylaxis (Svendsen et al., 2009 ).
The traits for integrin usage in cellular control of P IF in vivo are paralleled by cell-mediated contraction of three-dimensional reconstituted collagen gels in vitro. Thus, collagen-binding 1 integrins mediate, when present, the cell-collagen contacts that are necessary for contraction (Gullberg et al., 1990) ; in their absence integrin V 3 becomes operative (Grundström Grundström, Mosher, Sakai, & Rubin, 2003) . Integrin V 3 -directed contraction by myoblasts requires that the cells synthesize fibronectin, a synthesis that in these cells is stimulated by PDGF-BB van Wieringen et al., 2010) . Available data suggest that fibronectin forms a bridge between the collagen fibres and integrin V 3 thereby enabling collagen gel contraction van Wieringen et al., 2010) .
Fibronectin binds collagen monomers at a discrete collagen site that also binds collagenases, discoidin domain receptor 2, fibromodulin and fibrinogen (Farndale et al., 2008; Fields, 2014; Howes et al., 2014; Kalamajski, Bihan, Bonna, Rubin, & Farndale, 2016; Manka et al., 2012; Reyhani et al., 2014; van Wieringen et al., 2010) . This site is also recognized by the collagen-binding streptococcal protein CNE, which inhibits V 3 -directed, fibrin-or fibronectin-dependent collagen gel contraction by myoblasts (Reyhani et al., 2014; van Wieringen et al., 2010) .
Here we investigated the role of integrin V 3 -integrin in maintaining P IF in the dermis of mice with a constitutively perturbed function of collagen-binding 1 -integrins, such as in 11 1 -deficient mice (Svendsen et al., 2009 ). Furthermore, we investigated the potential role of collagen-binding proteins that may bridge the collagen fibres to cellular V 3 by investigating potential effects of the streptococcal protein CNE on cellular control of P IF .
METHODS

Ethical approval
The animal experiments were conducted according to the European Measurements of interstitial fluid pressure (P IF ) were performed on the dorsal side of the hind paw with the mouse lying on its back.
After a control measurement with intact circulation, the remaining measurements (90 min) were performed after circulatory arrest and the animal was killed with cervical dislocation in Group A (see below).
In Groups B and C (see below) the animals were killed with intravenous saturated KCl. Furthermore, the duration of anaesthesia in all three groups was no more than 5-10 min including measurement of control P IF and I.V. injections in any of the groups. Before and during the experiments sufficient depth of anaesthesia was confirmed by lack of response to hindlimb toe pinch.
Reagents
Purified NA/LE Hamster Anti-Mouse CD61 IgG 1 that blocks V 3 -integrin-mediated cell adhesion was obtained from BD Biosciences (San Jose, CA, USA). The streptococcal protein CNE was produced and purified as described earlier (Lannergård, Frykberg, & Guss, 2003) .
C48/80 was obtained from Sigma-Aldrich (St. Louis, MO, USA). from the study since a lack of response to C48/80 means that PDGF-BB will not have a lowered P IF to act on. One microlitre of PDGF-BB (0.7 g ml −1 ) was injected intra-dermally after 30 min either alone or combined with CNE at 0.7 mg ml −1 .
Interstitial fluid pressure
Effects of CNE in wild-type and 11 1 -deficient mice
After control measurement of P IF with intact circulation, the animals were given saturated KCl intravenously to induce circulatory arrest.
One microlitre of CNE at 0.7 g ml −1 was injected subcutaneously and measurement of P IF continued for 90 min.
Statistical methods
Data are presented as means ± SD unless specified otherwise.
Repeated measurements ANOVA and post-hoc test (Sidak's multiple comparison test) correcting for multiple corrects were used.
Measurements of P IF were compared using one-and two-tailed Student's t test as specified in Results. P < 0.05 was considered statistically significant.
RESULTS
Effects of anti-integrin 3 IgG on dermal interstitial fluid pressure
In accordance with previously reported findings showing that 1 -integrin and not V 3 is operative in maintaining P IF at homeostasis, local intradermal injection of anti-integrin 3 IgG in wild-type naïve C57BL/6 mice had no effect on P IF (Figure 1 ). In contrast, intradermal but not from its own control (P = 0.72) measured prior to injection of C48/80 (in both cases using paired comparison and two-tailed testing).
Effects of CNE in wild-type and 11 1 -deficient mice
Injection of 1 l 0.7 mg ml −1 CNE in wild-type and 11 1 -deficient ( 11 −/− ) mice did not change P IF compared to the respective controls ( Figure 3 ). P IF in both wild-type and 11 1 -deficient mice was unaffected by injection of CNE (P > 0.05 using one-way repeated ANOVA). P IF in the 11 1 -deficient mice was lower in this experimental series than in wild-type. The control P IF values did not, however, differ between wild-type and 11 1 -deficient mice in the experimental series shown in Figure 1 , nor in those reported by Svendsen et al. (2009) .
DISCUSSION
Here we show that the integrin V 3 functions physiologically to maintain the homeostatic P IF in mouse dermis lacking the integrin 11 1 . During acute inflammatory reactions collagen-binding 1 -integrins decouple and their role in controlling P IF is taken over by the V 3 integrin (Liden et al., 2006; Svendsen et al., 2008) . Our present data are a further elaboration on how P IF can be modulated by cellular and molecular pathways and show that the V 3 integrin can integrin in control of dermal P IF in mice (Svendsen et al., 2009) . Taken together with the data presented here, it is possible to conclude that the collagen-binding 1 -integrin 11 1 is a key operator in maintaining a homeostatic P IF in normal dermis. In mouse dermis lacking 11 1 ( 11 −/− mice), P IF was only marginally lowered after induction of anaphylaxis by the mast cell degranulator C48/80 (Svendsen et al., 2009 ) suggesting that V 3 integrin-operated P IF control works also during anaphylaxis, which is in line with previously published reports (Liden et al., 2006; Svendsen et al., 2008) .
In a previous publication, we presented data on a role of the collagen-binding 1 -integrin 2 1 in controlling P IF in rat dermis (Rodt et al., 1996) . This conclusion was based on experiments in which the anti-rat 2 1 monoclonal antibody Ha1/29 (Mendrick & Kelly, 1993) lowered P IF in naïve rat dermis. It is thus possible that mice and rats differ as to preferred usage of collagen-binding 1 -integrin to control dermal P IF . Alternatively, both integrins are required and perturbation of any of them distorts dermal P IF -control. It can furthermore not be excluded that the Ha1/29 antibody inhibits both 2 1 and 11 1 .
It is not clear whether collagen-binding 1 -integrins bind directly to collagen molecules in the ECM fibres in vivo or only via accessory proteins as has been suggested to be the case for chondrocyte binding to cartilage collagenous fibres (Woltersdorf et al., 2017) . Our present data do not discriminate between these two possibilities but together with previously reported data show that integrins play an important physiological role in controlling P IF .
To further delineate V 3 integrin-operated P IF control in mouse dermis deficient in the 11 1 integrin ( 11 −/− mice), we took advantage of the streptococcal protein CNE. CNE binds to and blocks a collagen site that is necessary for binding of several proteins that can function as a bridge between cellular V 3 and the collagen fibres, such as fibrin and fibronectin. Integrin V 3 -mediated contraction of collagen gels in vitro relies on these interactions and is inhibited by CNE (Reyhani et al., 2014; van Wieringen et al., 2010) . Our present data demonstrate an in vivo effect of CNE, namely that it inhibited PDGF BB-induced and integrin V 3 -mediated normalization of P IF that has been lowered by induction of anaphylaxis in naïve mouse dermis using the mast cell degranulator C48/80. This implies, first, that the ECM is altered during early innate immune responses. Second, that a collagen-binding site needs to be available in order for the cellular binding to ECM fibres via V 3 to occur, a defined site known to bind several proteins that can associate with collagen fibres (Farndale et al., 2008; Fields, 2014; Howes et al., 2014; Kalamajski et al., 2016; Manka et al., 2012; Reyhani et al., 2014; van Wieringen et al., 2010) . Based on our present finding that CNE had no effect on P IF in naïve mouse dermis lacking 11 1 ( 11 −/− mice) or in wild-type dermis it can be concluded that integrin V 3 -directed processes that are operative in P IF control during homeostasis differ from the dynamic changes resulting from acute inflammatory reactions. Based on the induction of an acute inflammation in mouse dermis lacking 11 1 ( 11 −/− mice) not resulting in a lowering of P IF , the present findings with CNE suggest the need for a change of ECM build-up in order for the tissue to be able to respond to inflammatory insults by forming oedema.
In conclusion, the present data show that integrin V 3 can fully substitute for loss of collagen-binding 1 -integrins with regard to maintaining a homeostatic dermal P IF. Taken together with results presented by Svendsen et al. (2009) , the data also imply that V 3 integrin-operated P IF control does not respond to acute inflammatory challenges and thereby does not enable oedema formation during innate immunity responses. Furthermore, our data show that whereas in normal dermis V 3 integrin-operated P IF control requires changes of the ECM build-up, they are not needed in dermis in which impaired collagen-binding 1 -integrin activity is a constitutive property.
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